!

COVID-19 Response

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Research

Chadi Calarge Lab Publications

Master
Content

Calarge CA, Devaraj S, Shulman RJ. Gut permeability and depressive symptom severity inunmedicated adolescents. J Affect Disord. 2019 Mar 1;246:586-594. PubMed PMID: 30605877.

Calarge CA, Mills JA, Karaviti L, Teixeira AL, Zemel BS, Garcia JM. Selective Serotonin Reuptake Inhibitors Reduce Longitudinal Growth in Risperidone-Treated Boys. J Pediatr. 2018 Oct;201:245-251. PubMed PMID: 29958671; PubMed Central PMCID: PMC6153035.

Calarge CA, Mills JA, Janz KF, Burns TL, Schlechte JA, Coryell WH, Zemel BS. The Effect of Depression, Generalized Anxiety, and Selective Serotonin Reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging Adults. J Bone Miner Res. 2017 Dec;32(12):2367-2374. PubMed PMID: 28815738; PubMed Central PMCID: PMC5732069.

Calarge CA, Mills JA, Janz KF, Burns TL, Coryell WH, Zemel BS. Body Composition in Adolescents During Treatment With Selective Serotonin Reuptake Inhibitors. Pediatrics. 2017 Jul;140(1)PubMed PMID: 28759400; PubMed Central PMCID: PMC5495528.

Calarge CA, Murry DJ, Ziegler EE, Arnold LE. Serum Ferritin, Weight Gain, Disruptive Behavior, and Extrapyramidal Symptoms in Risperidone-Treated Youth. J Child Adolesc Psychopharmacol 2016 Jun;26(5):471-7. PubMed PMID: 26894929; PubMed Central PMCID: PMC4931353.

Bahr SM, Tyler BC, Wooldridge N, Butcher BD, Burns TL, Teesch LM, Oltman CL, Azcarate-Peril MA, Kirby JR, Calarge CA. Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children. Transl Psychiatry. 2015 Oct 6;5:e652. PubMed PMID: 26440540; PubMed Central PMCID: PMC4930121.

Calarge CA, Schlechte JA, Burns TL, Zemel BS. The effect of psychostimulants on skeletal health in boys co-treated with risperidone. J Pediatr. 2015 Jun;166(6):1449-54.e1. PubMed PMID: 25863660; PubMed Central PMCID: PMC4446198.

Calarge C, Farmer C, DiSilvestro R, Arnold LE. Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2010 Dec;20(6):495-502. PubMed PMID: 21186968; PubMed Central PMCID: PMC3003494.

See a full list of publications.